Performance of JNJ Johnson & Johnson | -2.9% in 12m
Compare JNJ with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Johnson & Johnson with its related Sector/Index XLV
Performance Duell JNJ vs XLV
TimeFrame | JNJ | XLV |
---|---|---|
1 Day | 0.71% | 0.83% |
1 Week | 1.58% | 1.60% |
1 Month | -1.17% | -0.13% |
3 Months | -4.83% | -0.89% |
6 Months | -0.75% | 11.98% |
12 Months | -2.85% | 8.71% |
YTD | -4.31% | 3.10% |
Rel. Perf. 1m | -0.18 | |
Rel. Perf. 3m | -0.85 | |
Rel. Perf. 6m | -1.29 | |
Rel. Perf. 12m | -1.17 |
Is Johnson & Johnson a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Johnson & Johnson (XETRA:JNJ) is currently (May 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 63.68 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JNJ as of May 2024 is 124.66. This means that JNJ is currently overvalued and has a potential downside of -9.98% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JNJ as of May 2024 is 124.66. This means that JNJ is currently overvalued and has a potential downside of -9.98% (Sold with Premium).
Is JNJ a buy, sell or hold?
Johnson & Johnson has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of -2.85%.
In compare to Health Care Sector SPDR Fund, JNJ made -11.56% less over the last 12 months. Due to the underperformance, it is recommend to sell JNJ.
In compare to Health Care Sector SPDR Fund, JNJ made -11.56% less over the last 12 months. Due to the underperformance, it is recommend to sell JNJ.
Values above 0%: JNJ is performing better - Values below 0%: JNJ is underperforming
Compare JNJ with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -1.44% | -0.87% | -19.96% | -29.96% |
US NASDAQ 100 | QQQ | -2.12% | -1.11% | -19.35% | -39.79% |
US Dow Jones Industrial 30 | DIA | -1.23% | -1.13% | -15.64% | -20.71% |
German DAX 40 | DBXD | -1.12% | -1.66% | -22.02% | -17.93% |
UK FTSE 100 | ISFU | -0.77% | -5.34% | -17.19% | -13.58% |
Shanghai Shenzhen CSI 300 | CSI 300 | -0.53% | -5.01% | -2.34% | 9.26% |
Hongkong Hang Seng | HSI | -4.22% | -10.02% | -1.10% | 11.41% |
Japan Nikkei 225 | EXX7 | -0.69% | 1.82% | -16.35% | -22.19% |
India NIFTY 50 | INDA | 2.42% | -0.27% | -18.17% | -28.08% |
Brasil Bovespa | EWZ | -3.22% | -1.17% | -5.19% | -23.25% |
JNJ Johnson & Johnson vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -2.95% | 0.21% | -21.52% | -42.27% |
Consumer Discretionary | XLY | -0.07% | -0.05% | -11.24% | -24.66% |
Consumer Staples | XLP | -0.08% | -4.58% | -13.60% | -5.51% |
Energy | XLE | 1.91% | 3.19% | -13.96% | -23.05% |
Financial | XLF | -0.53% | 0.12% | -24.36% | -32.39% |
Health Care | XLV | -0.02% | -1.04% | -12.73% | -11.56% |
Industrial | XLI | -0.75% | -0.29% | -24.83% | -30.37% |
Materials | XLB | -1.25% | 0.66% | -20.56% | -20.00% |
Real Estate | XLRE | -1.82% | 2.16% | -11.63% | -7.09% |
Technology | XLK | -2.49% | -0.22% | -18.07% | -39.08% |
Utilities | XLU | -2.62% | -7.19% | -16.30% | -7.37% |
Aerospace & Defense | XAR | -2.12% | -3.35% | -18.23% | -28.36% |
Biotech | XBI | -5.29% | -1.20% | -27.21% | -9.26% |
Homebuilder | XHB | -1.50% | 1.36% | -38.71% | -52.67% |
Retail | XRT | -1.72% | -0.29% | -22.09% | -25.12% |
Does Johnson & Johnson outperform its market, is JNJ a Sector Leader?
No, over the last 12 months Johnson & Johnson (JNJ) made -2.85%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 8.71%.
Over the last 3 months JNJ made -4.83%, while XLV made -0.89%.
No, over the last 12 months Johnson & Johnson (JNJ) made -2.85%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 8.71%.
Over the last 3 months JNJ made -4.83%, while XLV made -0.89%.
Period | JNJ | XLV | S&P 500 |
---|---|---|---|
1 Month | -1.17% | -0.13% | -0.30% |
3 Months | -4.83% | -0.89% | 4.15% |
12 Months | -2.85% | 8.71% | 27.11% |